Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjögren’s Syndrome
Authors:
Open Access
- 22 November 2011
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 42 (1) , 35-44
Abstract
The mouse model is the one of the most frequently used and well-established animal models, and is currently used in many research areas. To date, various mouse models have been utilized to elucidate underlying causes of multifactorial autoimmune conditions, including pathological immune components and specific signaling pathways. This review summarizes the more recent mouse models for Sjögren’s syndrome, a systemic autoimmune disease characterized by lymphocytic infiltration in the exocrine glands, such as the salivary and lacrimal glands, and loss of secretory function, resulting in dry mouth and dry eyes in patients. Although every Sjögren’s syndrome mouse model resembles the major symptoms or phenotypes of Sjögren’s syndrome conditions in humans, the characteristics of each model are variable. Moreover, to date, there is no single mouse model that can completely replicate the human conditions. However, unique features of each mouse model provide insights into the roles of potential etiological and immunological factors in the development and progression of Sjögren’s syndrome. Here, we will overview the Sjögren’s syndrome mouse models. Lessons from these mouse models will aid us to understand underlying immune dysregulation in autoimmune diseases in general, and will guide us to direct future research towards appropriate diagnostic and therapeutic strategies.Keywords
This publication has 80 references indexed in Scilit:
- Modeling Sjögren's syndrome with Id3 conditional knockout miceImmunology Letters, 2011
- IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transferLaboratory Investigation, 2010
- Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathwayJournal of Experimental Medicine, 2009
- Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome–like autoimmune exocrinopathyJournal of Experimental Medicine, 2008
- Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndromeEuropean Journal of Immunology, 2008
- Salivary gland tissue expression of interleukin‐23 and interleukin‐17 in Sjögren's syndrome: Findings in humans and miceArthritis & Rheumatism, 2008
- B‐lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout miceImmunology, 2007
- Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinaseProceedings of the National Academy of Sciences, 2006
- Development of nephritis but not sialadenitis in autoimmune‐prone BAFF transgenic mice lacking marginal zone B cellsEuropean Journal of Immunology, 2006
- Id and developmentOncogene, 2001